In a public comment before the President's Council on Science and Technology (PCAST), ASHA expressed grave concern and opposition to the Council's recent recommendations related to accessibility to and affordability of hearing health care services. The PCAST recommendations included a new FDA classification of over-the-counter (OTC) hearing aids.